{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:12:56Z","timestamp":1793661176678,"version":"4.5.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10072-025-08417-y","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T03:43:26Z","timestamp":1755920606000},"page":"5351-5357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual cancers in Ataxia-Telangiectasia: a case report and literature review"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8732-0191","authenticated-orcid":false,"given":"Shaghayegh","family":"Khanmohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2999-2642","authenticated-orcid":false,"given":"Amirhossein","family":"Habibzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4320-7509","authenticated-orcid":false,"given":"Seyed Mohammad Kazem","family":"Nourbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0463-4257","authenticated-orcid":false,"given":"Mojtaba","family":"Fazel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5675-7526","authenticated-orcid":false,"given":"Erfan","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-0407","authenticated-orcid":false,"given":"Hassan","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3836-1827","authenticated-orcid":false,"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3351-9092","authenticated-orcid":false,"given":"Arash","family":"Kalantari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5578-6595","authenticated-orcid":false,"given":"Reza","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"issue":"9","key":"8417_CR1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1080\/1744666X.2020.1810570","volume":"16","author":"P Amirifar","year":"2020","unstructured":"Amirifar P, Ranjouri MR, Lavin M, Abolhassani H, Yazdani R, Aghamohammadi A (2020) Ataxia-telangiectasia: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management. Expert Rev Clin Immunol 16(9):859\u2013871","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"8417_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/pai.13020","volume":"30","author":"P Amirifar","year":"2019","unstructured":"Amirifar P, Ranjouri MR, Yazdani R, Abolhassani H, Aghamohammadi A (2019) Ataxia-telangiectasia: a review of clinical features and molecular pathology. Pediatr Allergy Immunol 30(3):277\u2013288","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"8417_CR3","first-page":"29","volume":"3","author":"T Moeini Shad","year":"2020","unstructured":"Moeini Shad T, Ranjouri MR, Amirifar P (2020) Clinical manifestations in Iranian ataxia telangiectasia patients. Immunol Genet J 3(1):29\u201340","journal-title":"Immunol Genet J"},{"issue":"1","key":"8417_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ajh.21903","volume":"86","author":"RS Shapiro","year":"2011","unstructured":"Shapiro RS (2011) Malignancies in the setting of primary immunodeficiency: implications for hematologists\/oncologists. Am J Hematol 86(1):48\u201355","journal-title":"Am J Hematol"},{"issue":"1","key":"8417_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10875-024-01810-w","volume":"45","author":"S Fekrvand","year":"2024","unstructured":"Fekrvand S, Abolhassani H, Esfahani ZH, Fard NNG, Amiri M, Salehi H et al (2024) Cancer trends in inborn errors of immunity: A systematic review and Meta-Analysis. J Clin Immunol 45(1):34","journal-title":"J Clin Immunol"},{"issue":"6","key":"8417_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.ejpn.2018.07.006","volume":"22","author":"A Nissenkorn","year":"2018","unstructured":"Nissenkorn A, Erlich T, Zilberman DE, Sarouk I, Krauthammer A, Kitrey ND et al (2018) Secondary enuresis and urological manifestations in children with ataxia telangiectasia. Eur J Paediatr Neurol 22(6):1118\u20131123","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"8417_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF00428672","volume":"389","author":"F Yoshitomi","year":"1980","unstructured":"Yoshitomi F, Zaitsu Y, Tanaka K (1980) Ataxia-telangiectasia with renal cell carcinoma and hepatoma. Virchows Arch Pathol Anat Histol 389(1):119\u2013125","journal-title":"Virchows Arch Pathol Anat Histol"},{"issue":"6","key":"8417_CR8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s10875-021-01053-z","volume":"41","author":"A Aghamohammadi","year":"2021","unstructured":"Aghamohammadi A, Rezaei N, Yazdani R, Delavari S, Kutukculer N, Topyildiz E et al (2021) Consensus middle East and North Africa registry on inborn errors of immunity. J Clin Immunol 41(6):1339\u20131351","journal-title":"J Clin Immunol"},{"issue":"7","key":"8417_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s10875-018-0556-1","volume":"38","author":"H Abolhassani","year":"2018","unstructured":"Abolhassani H, Kiaee F, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T et al (2018) Fourth update on the Iranian National registry of primary immunodeficiencies: integration of molecular diagnosis. J Clin Immunol 38(7):816\u2013832","journal-title":"J Clin Immunol"},{"issue":"3","key":"8417_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A (1999) Diagnostic criteria for primary immunodeficiencies. Clin Immunol 93(3):190\u2013197","journal-title":"Clin Immunol"},{"issue":"1","key":"8417_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jaip.2022.10.003","volume":"11","author":"S Baris","year":"2023","unstructured":"Baris S, Abolhassani H, Massaad MJ, Al-Nesf M, Chavoshzadeh Z, Keles S et al (2023) The middle East and North Africa diagnosis and management guidelines for inborn errors of immunity. J Allergy Clin Immunol Pract 11(1):158\u2013180 e11","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"8417_CR12","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jaci.2017.06.049","volume":"141","author":"H Abolhassani","year":"2018","unstructured":"Abolhassani H, Chou J, Bainter W, Platt CD, Tavassoli M, Momen T et al (2018) Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency. J Allergy Clin Immunol 141(4):1450\u20131458","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"8417_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10875-016-0260-y","volume":"36","author":"M Fang","year":"2016","unstructured":"Fang M, Abolhassani H, Lim CK, Zhang J, Hammarstrom L (2016) Next generation sequencing data analysis in primary immunodeficiency disorders - future directions. J Clin Immunol 36(Suppl 1):68\u201375","journal-title":"J Clin Immunol"},{"issue":"2","key":"8417_CR14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jaci.2024.10.023","volume":"155","author":"A Magnarelli","year":"2025","unstructured":"Magnarelli A, Liu Q, Wang F, Peng XP, Wright J, Oak N et al (2025) Prevalence and outcomes of cancer and treatment-associated toxicities for patients with ataxia telangiectasia. J Allergy Clin Immunol 155(2):640\u2013649","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"8417_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/jcp.54.7.512","volume":"54","author":"J Boultwood","year":"2001","unstructured":"Boultwood J (2001) Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J Clin Pathol 54(7):512\u2013516","journal-title":"J Clin Pathol"},{"issue":"1","key":"8417_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s10875-020-00881-9","volume":"41","author":"T Moeini Shad","year":"2021","unstructured":"Moeini Shad T, Yousefi B, Amirifar P, Delavari S, Rae W, Kokhaei P et al (2021) Variable abnormalities in T and B cell subsets in ataxia telangiectasia. J Clin Immunol 41(1):76\u201388","journal-title":"J Clin Immunol"},{"key":"8417_CR17","doi-asserted-by":"publisher","DOI":"10.2174\/1871530322666220208111837","author":"S Khanmohammadi","year":"2022","unstructured":"Khanmohammadi S, Moeini Shad T, Delavari S, Shirmast P, Bagheri Y, Azizi G et al (2022) Evaluation of specific antibody responses in patients with selective IgA deficiency and ataxia telangiectasia. Endocrine, Metabolic & Immune Disorders. https:\/\/doi.org\/10.2174\/1871530322666220208111837","journal-title":"Endocrine, Metabolic & Immune Disorders"},{"key":"8417_CR18","doi-asserted-by":"publisher","first-page":"972952","DOI":"10.3389\/fped.2022.972952","volume":"10","author":"A Szczawi\u0144ska-Pop\u0142onyk","year":"2022","unstructured":"Szczawi\u0144ska-Pop\u0142onyk A, T\u0105polska-J\u00f3\u017awiak K, Schwartzmann E, Pietrucha B (2022) Infections and immune dysregulation in ataxia-telangiectasia children with hyper-IgM and non-hyper-IgM phenotypes: a single-center experience. Front Pediatr 10:972952","journal-title":"Front Pediatr"},{"issue":"2","key":"8417_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1365-2249.2008.03684.x","volume":"153","author":"ER Staples","year":"2008","unstructured":"Staples ER, McDermott EM, Reiman A, Byrd PJ, Ritchie S, Taylor AM et al (2008) Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol 153(2):214\u2013220","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"8417_CR20","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1097\/MPH.0000000000001537","volume":"42","author":"MF Jacobs","year":"2020","unstructured":"Jacobs MF, Anderson B, Opipari VP, Mody R (2020) Hepatosplenic \u03b1\u03b2 T-Cell lymphoma as second malignancy in young adult patient with previously undiagnosed Ataxia-Telangiectasia. J Pediatr Hematol Oncol 42(6):e463\u2013e5","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"8417_CR21","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4161\/cc.9.3.10556","volume":"9","author":"Q Cheng","year":"2010","unstructured":"Cheng Q, Chen J (2010) Mechanism of p53 stabilization by ATM after DNA damage. Cell Cycle 9(3):472\u2013478","journal-title":"Cell Cycle"},{"issue":"12","key":"8417_CR22","first-page":"3989","volume":"109","author":"N Davies","year":"2024","unstructured":"Davies N, Francis T, Oldreive C, Azam M, Wilson J, Byrd PJ et al (2024) Genome-scale clustered regularly interspaced short palindromic repeats screen identifies nucleotide metabolism as an actionable therapeutic vulnerability in diffuse large B-cell lymphoma. Haematologica 109(12):3989\u20134006","journal-title":"Haematologica"},{"issue":"7","key":"8417_CR23","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/00043426-200407000-00009","volume":"26","author":"A Makis","year":"2004","unstructured":"Makis A, Polychronopoulou S, Haidas S (2004) Osteosarcoma as a second tumor after treatment for primary non-Hodgkin\u2019s lymphoma in a child with ataxia-telangiectasia: presentation of a case and review of possible pathogenetic mechanisms. J Pediatr Hematol Oncol 26(7):444\u2013446","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"8417_CR24","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1016\/j.clgc.2019.01.003","volume":"17","author":"W Ren","year":"2019","unstructured":"Ren W, Xue B, Chen M, Liu L, Zu X (2019) Low expression of ATM indicates a poor prognosis in clear cell renal cell carcinoma. Clin Genitourin Cancer 17(3):e433\u2013e9","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"8417_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10875-025-01857-3","volume":"45","author":"F Salami","year":"2025","unstructured":"Salami F, Shad TM, Fathi N, Mojtahedi H, Esmaeili M, Shahkarami S et al (2025) ATM expression and activation in ataxia telangiectasia patients with and without class switch recombination defects. J Clin Immunol 45(1):67","journal-title":"J Clin Immunol"},{"issue":"15","key":"8417_CR26","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1182\/blood-2012-08-448068","volume":"121","author":"LM Morton","year":"2013","unstructured":"Morton LM, Dores GM, Tucker MA, Kim CJ, Onel K, Gilbert ES et al (2013) Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the united states, 1975\u20132008. Blood 121(15):2996\u20133004","journal-title":"Blood"},{"issue":"19","key":"8417_CR27","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1002\/cncr.30164","volume":"122","author":"N Donin","year":"2016","unstructured":"Donin N, Filson C, Drakaki A, Tan HJ, Castillo A, Kwan L et al (2016) Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer 122(19):3075\u20133086","journal-title":"Cancer"},{"issue":"6","key":"8417_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/ACI.0000000000000863","volume":"22","author":"Y Wang","year":"2022","unstructured":"Wang Y, Abolhassani H (2022) Updates of cancer hallmarks in patients with inborn errors of immunity. Curr Opin Allergy Clin Immunol 22(6):352\u2013363","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"8417_CR29","doi-asserted-by":"publisher","first-page":"720025","DOI":"10.3389\/fimmu.2021.720025","volume":"12","author":"H Abolhassani","year":"2021","unstructured":"Abolhassani H, Wang Y, Hammarstr\u00f6m L, Pan-Hammarstr\u00f6m Q (2021) Hallmarks of cancers: primary antibody deficiency versus other inborn errors of immunity. Front Immunol 12:720025","journal-title":"Front Immunol"},{"issue":"2","key":"8417_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","volume":"33","author":"F Suarez","year":"2015","unstructured":"Suarez F, Mahlaoui N, Canioni D, Andriamanga C, d\u2019Enghien CD, Brousse N et al (2015) Incidence, presentation, and prognosis of malignancies in Ataxia-Telangiectasia: A report from the French National registry of primary immune deficiencies. J Clin Oncol 33(2):202\u2013208","journal-title":"J Clin Oncol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08417-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08417-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08417-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T03:14:16Z","timestamp":1759288456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08417-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["8417"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08417-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was approved by the Ethics Committee of the Tehran University of Medical Sciences (IR.TUMS.CHMC.REC.1403.179). Informed consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participant"}},{"value":"The authors have no conflict of interests related to this publication. The authors have no financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no conflict of interest related to this publication. The authors have no financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}